Fungal infections caused by multi-drug resistant (MDR) pathogens pose a growing threat to human health. The identification of new and safe antifungals with novel modes of action is now vital.

APT's platform is based on a growing library of bacteriophages, viruses that infect and kill bacteria, that could be used to treat a range of multi-drug resistant (MDR) pathogens, and the Fund's $ ...

Now, its spent some of that budget on a new antifungal from Scynexis that could tackle an emerging multidrug-resistant (MDR) pathogen. The exclusive licensing deal covers Brexafemme (ibrexafungerp ...

Biologists from the University of the Philippines - Diliman College of Science are looking into the rapid rise of multidrug-resistant (MDR) bacteria such as salmonella in poultry products.

† Alternative diagnostic criteria: ≥1 of parameters 1.2 and ≥1 of parameters 3.4. VAP may be diagnosed by a CPIS ≥6 [28,29]. ‡ Applicable for VAP only. BAL: Bronchoalveolar lavage ...

TAXIS Pharmaceuticals is developing first-in-class anti-resistance drugs to help re-engage widely prescribed but resistance-prone generic antibiotics to treat patients with multidrug-resistant ...

The rapid rise of multidrug-resistant (MDR) bacteria makes treating bacterial infections increasingly difficult, and the widespread use of antibiotics in agricultural, clinical, and residential ...

Additionally, there is growing evidence that saccharin inhibits members of the oral microbiome (e.g., Porphyromonas gingivalis), laboratory-model bacteria, and even multidrug-resistant (MDR ...

In recent years, colistin has attracted considerable interest as an antibiotic for use against MDR strains ... a treatment option against pathogenic bacteria.

Biologists from the University of the Philippines - Diliman College of Science are looking into the rapid rise of multidrug-resistant (MDR) bacteria such as salmonella in poultry products. The study ...